Gregory J. Riely, MD, PhD | Authors

Articles

Dr. Gregory Riely on Potential Treatment for Patients With MET Exon 14 Mutation

November 04, 2015

Gregory J. Riely, MD, PhD, vice chair of the Clinical Trials Office in the Department of Medicine, Memorial Sloan Kettering Cancer Center, talks about non-small cell lung cancer (NSCLC) MET exon 14 mutations and their response to drugs like cabozantinib and crizotinib.

Lung Cancer Research and the Stigma of Cigarette Smoking

May 23, 2014

Gregory J. Riely, MD, PhD, vice chair, Clinical Trials Office, Department of Medicine, Memorial Sloan Kettering Cancer Center, discusses the impact of the stigma of cigarette smoking on lung cancer research.